Systemic hemodynamic , neurohormonal , and renal effects of a steady - state infusion of human brain natriuretic peptide in <font color="blue">patients_5</font> <font color="blue">with_5</font> <font color="blue">hemodynamically_5</font> <font color="blue">decompensated_5</font> <font color="blue">heart_5</font> <font color="blue">failure_5</font> <font color="blue">._5</font> <font color="blue">
<br>
<br>_1</font> BACKGROUND Human brain natriuretic peptide ( hBNP ) is a promising agent for the treatment of decompensated cardiac failure . However , the systemic hemodynamic , neurohormonal , and renal effects of hBNP have been incompletely studied in <font color="blue">human_1</font> <font color="blue">heart_1</font> <font color="blue">failure_1</font> <font color="blue">._1</font> 
<br> METHODS AND RESULTS <font color="blue">The_1</font> <font color="blue">effects_1</font> <font color="blue">of_1</font> <font color="blue">a_1</font> <font color="blue">continuous_1</font> <font color="blue">4-hour_1</font> <font color="blue">infusion_1</font> <font color="blue">of_1</font> <font color="blue">hBNP_1</font> <font color="blue">were_1</font> <font color="blue">determined_1</font> <font color="blue">in_1</font> <font color="blue">16_6</font> <font color="blue">decompensated_6</font> <font color="blue">heart_6</font> <font color="blue">failure_6</font> <font color="blue">patients_6</font> <font color="blue">in_2</font> <font color="blue">an_2</font> <font color="blue">invasive_2</font> <font color="blue">,_2</font> <font color="blue">randomized_2</font> <font color="blue">,_2</font> <font color="blue">double_2</font> <font color="blue">-_2</font> <font color="blue">blind_2</font> <font color="blue">,_2</font> <font color="blue">placebo_2</font> <font color="blue">-_2</font> <font color="blue">controlled_2</font> <font color="blue">study_2</font> <font color="blue">._2</font> <font color="blue">Patients_1</font> <font color="blue">were_1</font> <font color="blue">evaluated_1</font> <font color="blue">during_1</font> <font color="blue">three_1</font> <font color="blue">4-hour_1</font> <font color="blue">study_1</font> <font color="blue">periods_1</font> <font color="blue">:_1</font> <font color="blue">baseline_1</font> <font color="blue">,_1</font> <font color="blue">treatment_1</font> <font color="blue">(_1</font> <font color="blue">placebo_1</font> <font color="blue">[_1</font> <font color="blue">n_1</font> <font color="blue">=_1</font> <font color="blue">4_1</font> <font color="blue">]_1</font> <font color="blue">versus_1</font> <font color="blue">hBNP_1</font> <font color="blue">0.025_1</font> <font color="blue">or_1</font> <font color="blue">0.05_1</font> <font color="blue">microgram_1</font> <font color="blue">/_1</font> <font color="blue">kg_1</font> <font color="blue">/_1</font> <font color="blue">min_1</font> <font color="blue">[_1</font> <font color="blue">n_1</font> <font color="blue">=_1</font> <font color="blue">12_1</font> <font color="blue">]_1</font> <font color="blue">)_1</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">post_1</font> <font color="blue">-_1</font> <font color="blue">treatment_1</font> <font color="blue">._1</font> <font color="blue">Urinary_1</font> <font color="blue">volume_1</font> <font color="blue">losses_1</font> <font color="blue">were_1</font> <font color="blue">replaced_1</font> <font color="blue">hourly_1</font> <font color="blue">to_1</font> <font color="blue">separate_1</font> <font color="blue">the_1</font> <font color="blue">vasodilatory_1</font> <font color="blue">and_1</font> <font color="blue">diuretic_1</font> <font color="blue">effects_1</font> <font color="blue">of_1</font> <font color="blue">hBNP_1</font> <font color="blue">._1</font> <font color="blue">Two_1</font> <font color="blue">patients_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">hBNP_1</font> <font color="blue">group_1</font> <font color="blue">were_1</font> <font color="blue">excluded_1</font> <font color="blue">from_1</font> <font color="blue">the_1</font> <font color="blue">analysis_1</font> <font color="blue">because_1</font> <font color="blue">of_1</font> <font color="blue">adverse_1</font> <font color="blue">events_1</font> <font color="blue">._1</font> hBNP significantly ( P < .001 ) reduced right atrial pressure and pulmonary capillary wedge pressure by approximately 30% and 40% , respectively . hBNP also significantly lowered systemic vascular resistance from 1722 + /- 139 to 1101 + /- 83 dynes.s.cm-5 ( P < .05 ) . These unloading effects of hBNP produced a 28% increase in cardiac index ( P < .05 ) with no change in heart rate . Compared to placebo , hBNP decreased plasma norepinephrine and aldosterone . Renal hemodynamics were unaffected by hBNP ; however , most patients were resistant to its natriuretic effect . 
<br> CONCLUSIONS 1 ) The predominant hemodynamic effects of hBNP were a decrease in cardiac preload and systemic vascular resistance . 2 ) hBNP also improved cardiac output without increasing heart rate . 3 ) Plasma norepinephrine and aldosterone levels decreased during hBNP infusion . 4 ) hBNP is pharmacologically active and has potential in the therapy for decompensated heart failure .